-
The adenomatous polyp (ADP) is recognized as the primary predecessor of colon cancer (CCA), prompting management strategies to identify and remove ADP.
-
Two recent studies suggest that rapid TIA evaluation and treatment can reduce stroke risk.
-
Bendamustine has received FDA approval, after priority review, for the treatment of chronic lymphocytic leukemia.
-
A statistically significant improvement in symptoms was observed in the treatment groups, with the honey-child group scoring the best, and the no treatment group doing the most poorly.
-
Mild TBI may be associated with brain microhemorrhages and white matter disruption, even with mild or absent symptoms of a postconcussion syndrome.
-
The proton pump inhibitor rabeprazole is said to provide rapid acid inhibition, but clinical implications of this have been uncertain. This study shows that a single dose of rabeprazole 20 mg administered 5 hours before therapeutic dosing of aspirin significantly decreases gastroduodenal damage.
-
The Women's Health Initiative (WHI) is a randomized controlled trial which is evaluating cancer and disease risk among healthy menopausal women aged 50-79 years.
-
FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
Chronic wounds represent a significant portion of the complaints seen by physicians, especially in the primary care setting. Visits for wound care account for just over 2% of all visits to office-based physicians in the United States.
-